The Hypotension Prediction Index in Free Flap Transplant in Head and Neck Surgery.
Hypotension, Head and Neck Cancer, Perioperative Complication
About this trial
This is an interventional prevention trial for Hypotension focused on measuring Hypotension, Hypotension Prediction Index, Free Flap Transplant, Head and Neck Cancer, Perioperative Complications
Eligibility Criteria
Inclusion Criteria: Patients qualified to head and neck free flap surgery Written informed consent Exclusion Criteria: Patients under 18 years Lack of health insurance Pregnancy Known history of congenital heart disease, severe aortic and/or mitral stenosis, heart failure and ejection fraction < 35 % Persistent atrial fibrillation and other arrhythmias impairing arterial pressure-based cardiac output (APCO) monitoring
Sites / Locations
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Standard Therapy Group
Hypotension Prediction Index Group
The standard therapy group patients will have invasive blood pressure monitoring + standard medical therapy. The therapeutic decision regarding treatment of hypotension, the use of fluids and vasopressors will be determined by the anaesthesia team. The decisions will be based on the information from the standard invasive blood pressure monitoring.
The HPI-group will have the HPI based monitoring with the Acumen IQ sensor (Edwards Lifesciences) and the HPI algorithm connected also to the HemoSphere platform (Edwards Lifesciences). The hemodynamic management will be based on the HPI indications and the specific algorithm, which considers hypovolemia, impaired contractility and vasodilatation. An alert pops up on the monitor screen when the HPI values exceeds 85 and then the clinician needs to make therapeutic decision in order to avoid the hypotensive episode.